Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Abagovomab biosimilar, Whole Mab: Anti-CA125/MUC16 therapeutic antibody |
Abagovomab |
NA |
CA125/MUC16 |
Whole mAb |
||
Pre-Made Abelacimab biosimilar, Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA therapeutic antibody |
Abelacimab |
NA |
F11 |
Whole mAb |
||
Pre-Made Abituzumab biosimilar, Whole mAb, Anti-ITGAV Antibody: Anti-CD51/MSK8/VNRA/VTNR therapeutic antibody |
Abituzumab |
NA |
ITGAV |
Whole mAb |
||
Pre-Made Abrezekimab biosimilar, Fab, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody |
Abrezekimab |
NA |
IL13 |
Fab |
||
Pre-Made Abrilumab biosimilar, Whole mAb, Anti-¦Á4¦Â7/Integrin alpha 4 beta 7 Antibody: Anti-LPAM?1 therapeutic antibody |
Abrilumab |
NA |
α4β7/Integrin alpha 4 beta 7 |
Whole mAb |
||
Pre-Made Acapatamab biosimilar, Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody |
Acapatamab |
NA |
FOLH1/GCPII,CD3E |
Bispecific scFv |
||
Pre-Made Acasunlimab biosimilar, Bispecific mAb, Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1;ILA/4-1BB/CDw137 Antibod: Anti-CD274/PD-L1;TNFRSF9/CD137 therapeutic antibody |
Acasunlimab |
NA |
CD274/PD-L1,TNFRSF9/CD137 |
Bispecific mAb |
||
Pre-Made Actoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody |
Actoxumab |
NA |
Toxin A |
Whole mAb |
||
Pre-Made Adalimumab biosimilar, Whole mAb, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody |
Adalimumab |
NA |
TNFA/TNF |
Whole mAb |
||
Pre-Made Adebrelimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Adebrelimab |
NA |
CD274/PD-L1 |
Whole mAb |
||
Pre-Made Aducanumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody |
Aducanumab |
NA |
APP |
Whole mAb |
||
Pre-Made Afasevikumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody |
Afasevikumab |
NA |
IL17A/IL17 |
Whole mAb |
||
Pre-Made Afutuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Afutuzumab |
Obinutuzumab |
MS4A1/CD20 |
Whole mAb |
||
Pre-Made Alacizumab biosimilar, di-Fab, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody |
Alacizumab |
NA |
KDR |
di-Fab |
||
Pre-Made Alemtuzumab biosimilar, Whole mAb, Anti-CD52 Antibody: Anti-HE5/CDW52/EDDM5 therapeutic antibody |
Alemtuzumab |
NA |
CD52 |
Whole mAb |
||
Pre-Made Alirocumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody |
Alirocumab |
NA |
PCSK9 |
Whole mAb |
||
Pre-Made Alomfilimab biosimilar, Whole mAb, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody |
Alomfilimab |
NA |
ICOS |
Whole mAb |
||
Pre-Made Alnuctamab biosimilar, Bispecific mAb with Domain Crossover, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Alnuctamab |
NA |
TNFRSF17,CD3E |
Bispecific mAb with Domain Crossover |
||
Pre-Made Alsevalimab biosimilar, Whole mAb, Anti-VTCN1 Antibody: Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1 therapeutic antibody |
Alsevalimab |
NA |
VTCN1 |
Whole mAb |
||
Pre-Made Amatuximab biosimilar, Whole mAb, Anti-MSLN Antibody: Anti-MPF/SMRP therapeutic antibody |
Amatuximab |
NA |
MSLN |
Whole mAb |
||
Pre-Made Amivantamab biosimilar, Bispecific mAb, Anti-EGFR;MET Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody |
Amivantamab |
NA |
EGFR,MET |
Bispecific mAb |
||
Pre-Made Amlitelimab biosimilar, Whole mAb, Anti-TNFSF4/OX40 Antibody: Anti-CD134L/CD252/GP34/OX-40L/OX4OL/TNLG2B/TXGP1 therapeutic antibody |
Amlitelimab |
NA |
TNFSF4/OX40 |
Whole mAb |
||
Pre-Made Anbenitamab biosimilar, Bispecific mAb: Anti-ERBB2 (Domain II);ERBB2 (Domain IV) therapeutic antibody |
Anbenitamab |
NA |
ERBB2 (Domain II),ERBB2 (Domain IV) |
Bispecific/biparatopic |
||
Pre-Made Andecaliximab biosimilar, Whole mAb, Anti-MMP9/MMP-9 Antibody: Anti-CLG4B/GELB/MANDP2 therapeutic antibody |
Andecaliximab |
NA |
MMP9/MMP-9 |
Whole mAb |
||
Pre-Made Anetumab biosimilar, Whole mAb ADC, Anti-MSLN Antibody: Anti-MPF/SMRP therapeutic antibody |
Anetumab |
NA |
MSLN |
Whole mAb ADC |
||
Pre-Made Anifrolumab biosimilar, Whole mAb, Anti-IFNAR1 Antibody: Anti-AVP/IFN-alpha-REC/IFNAR/IFNBR/IFRC therapeutic antibody |
Anifrolumab |
NA |
IFNAR1 |
Whole mAb |
||
Pre-Made Anrukinzumab biosimilar, Whole mAb, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody |
Anrukinzumab |
NA |
IL13 |
Whole mAb |
||
Pre-Made Ansuvimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP1 therapeutic antibody |
Ansuvimab |
NA |
Zaire Ebolavirus GP1 |
Whole mAb |
||
Pre-Made Apamistamab biosimilar, Whole mAb Radiolabelled, Anti-PTPRC Antibody: Anti-B220/CD45/CD45R/GP180/L-CA/LCA/LY5/T200 therapeutic antibody |
Apamistamab |
NA |
PTPRC |
Whole mAb Radiolabelled |
||
Pre-Made Apitegromab biosimilar, Whole Mab: Anti-pro-GDF-8 therapeutic antibody |
Apitegromab |
NA |
pro-GDF-8 |
Whole mAb |
||
Pre-Made Aprutumab biosimilar, Whole mAb ADC, Anti-FGFR2 Antibody: Anti-BBDS/BEK/BFR-1/CD332/CEK3/CFD1/ECT1/JWS/K-SAM/KGFR/TK14/TK25 therapeutic antibody |
Aprutumab |
NA |
FGFR2 |
Whole mAb ADC |
||
Pre-Made Ascrinvacumab biosimilar, Whole mAb, Anti-ACVRL1 Antibody: Anti-ACVRLK1/ALK-1/ALK1/HHT/HHT2/ORW2/SKR3/TSR-I therapeutic antibody |
Ascrinvacumab |
NA |
ACVRL1 |
Whole mAb |
||
Pre-Made Astegolimab biosimilar, Whole mAb, Anti-IL1RL1/ST2 Antibody: Anti-DER4/FIT-1/IL33R/T1 therapeutic antibody |
Astegolimab |
NA |
IL1RL1/ST2 |
Whole mAb |
||
Pre-Made Atezolizumab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Atezolizumab |
NA |
CD274/PD-L1 |
Whole mAb |
||
Pre-Made Atibuclimab biosimilar, Whole Mab: Anti-CD14 therapeutic antibody |
Atibuclimab |
NA |
CD14 |
Whole mAb |
||
Pre-Made Atidortoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody |
Atidortoxumab |
NA |
Toxin A |
Whole mAb |
||
Pre-Made Atinumab biosimilar, Whole mAb, Anti-RTN4 Antibody: Anti-ASY/NI220/250/NOGO/NSP/NSP-CL/Nbla00271/Nbla10545/RTN-X-B1-B2 therapeutic antibody |
Atinumab |
NA |
RTN4 |
Whole mAb |
||
Pre-Made Atoltivimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody |
Atoltivimab |
NA |
Zaire Ebolavirus GP |
Whole mAb |
||
Pre-Made Avdoralimab biosimilar, Whole mAb, Anti-C5AR1 Antibody: Anti-C5AR/C5R1/CD88 therapeutic antibody |
Avdoralimab |
NA |
C5AR1 |
Whole mAb |
||
Pre-Made Avelumab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Avelumab |
NA |
CD274/PD-L1 |
Whole mAb |
||
Pre-Made Avizakimab biosimilar, Whole mAb, Anti-IL21 Antibody: Anti-CVID11/IL-21/Za11 therapeutic antibody |
Avizakimab |
NA |
IL21 |
Whole mAb |
||
Pre-Made Axatilimab biosimilar, Whole mAb, Anti-CSF1R Antibody: Anti-FMS/CSFR/FIM2/HDLS/C-FMS/CD115/HDLS1/CSF-1R/BANDDOS/M-CSF-R therapeutic antibody |
Axatilimab |
NA |
CSF1R |
Whole mAb |
||
Pre-Made Azintuxizumab biosimilar, Whole mAb ADC, Anti-SLAMF7/CS1 Antibody: Anti-19A/CD319/CRACC therapeutic antibody |
Azintuxizumab |
NA |
SLAMF7/CS1 |
Whole mAb ADC |
||
Pre-Made Balstilimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Balstilimab |
NA |
PDCD1/PD-1 |
Whole mAb |
||
Pre-Made Bamlanivimab biosimilar, Whole Mab: Anti-SARS-CoV-2 Spike therapeutic antibody |
Bamlanivimab |
NA |
SARS-CoV-2 Spike |
Whole mAb |
||
Pre-Made Bapineuzumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody |
Bapineuzumab |
NA |
APP |
Whole mAb |
||
Pre-Made Bapotulimab biosimilar, Whole mAb, Anti-ILDR2 Antibody: Anti-C1orf32/dJ782G3.1 therapeutic antibody |
Bapotulimab |
NA |
ILDR2 |
Whole mAb |
||
Pre-Made Barecetamab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody |
Barecetamab |
NA |
ERBB3/Erbb-3 |
Whole mAb |
||
Pre-Made Basiliximab biosimilar, Whole mAb, Anti-IL2RA Antibody: Anti-CD25/IDDM10/IL2R/IMD41/TCGFR/p55 therapeutic antibody |
Basiliximab |
NA |
IL2RA |
Whole mAb |
||
Pre-Made Batoclimab biosimilar, Whole mAb, Anti-FCGRT Antibody: Anti-FCRN/FcgammaRn/alpha-chain therapeutic antibody |
Batoclimab |
NA |
FCGRT |
Whole mAb |
